Raveum Appoints Global Biopharma Executive Chintan Ghedia to Board of Directors, Reinforcing Commitment to Trust, Access, and Global Real Estate Investing

As a board member, Ghedia will advise on go-to-market strategy, strategic partnerships, and ensuring that Raveum remains nimble and disciplined as it broadens its footprint.

“Growing up in India, I saw firsthand how limited access to financial opportunity can shape, and sometimes restrict, an individual’s path to growth and prosperity,” said Ghedia. “That’s why Raveum’s mission deeply resonates with me – it is democratizing access to global real estate while building trust and advancing financial literacy.”

Chintan Ghedia is a results-driven pharmaceutical executive with over 20 years of experience commercializing life-changing cancer medicines across the world. Ghedia is recognized for complex launches, managed multi-market P&Ls, and elevating high-performing senior-level teams to launch and scale innovative cancer medicines across highly regulated, complex global markets.

With this appointment, Raveum strengthens its leadership as it continues building a globally inclusive, trust led U.S. real estate investment platform designed for long term participation and resilience.

About Raveum

Raveum is a global investment platform dedicated to expanding access to U.S. real estate through fractional ownership. Built on principles of transparency and institutional governance, Raveum provides a structured pathway for international investors to participate in high-quality real estate assets, fostering global financial inclusivity.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.